Richard N. Levy, Director at UNIGENE LABORATORIES INC (UGNE), bought 101,100 shares at $0.69 ($71K) on 2010-12-15, disclosed to the SEC on 2010-12-17.
Open-market purchase of $71k UGNE by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.69 | 75,000 | $52K | 73.4% |
| 2 | $0.72 | 26,100 | $19K | 26.6% |
| Total | $0.70 avg | 101,100 | $71K | 100% |
| Filing → |
| BKKT | SELL | 2023-12-20 | $956K | — | Filing → |
| BKKT | SELL | 2023-12-19 | $581K | — | Filing → |
| BKKT | SELL | 2023-12-06 | $165K | — | Filing → |